Cargando…
Efficacy of Tasimelteon (HETLIOZ®) in the Treatment of Jet Lag Disorder Evaluated in an 8-h Phase Advance Model; a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Background: Most travelers experience Jet Lag Disorder (JLD) symptoms due to misalignment of their circadian rhythms with respect to the new time zone. We assessed the efficacy and safety of tasimelteon (HETLIOZ®) in healthy participants using a laboratory model of JLD induced by an 8-h phase advanc...
Autores principales: | Polymeropoulos, Christos M., Mohrman, Michael A., Keefe, Madison S., Brzezynski, Jennifer L., Wang, Jingyuan, Prokosch, Lydia S., Polymeropoulos, Vasilios M., Xiao, Changfu, Birznieks, Gunther, Polymeropoulos, Mihael H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381312/ https://www.ncbi.nlm.nih.gov/pubmed/32754110 http://dx.doi.org/10.3389/fneur.2020.00611 |
Ejemplares similares
-
Once-daily tasimelteon (VEC-162) for jet lag following transmeridian travel: A multicenter, randomized, double-blind, placebo-controlled trial
por: Polymeropoulos, Christos M., et al.
Publicado: (2022) -
Simulated driving performance in healthy adults after night‐time administration of 20 mg tasimelteon
por: Torres, Rosarelis, et al.
Publicado: (2021) -
Case report: A patient with Delayed Sleep-Wake Phase Disorder and Optic Nerve Hypoplasia treated with tasimelteon: a case study
por: Smieszek, Sandra P., et al.
Publicado: (2023) -
Tradipitant in the Treatment of Motion Sickness: A Randomized, Double-Blind, Placebo-Controlled Study
por: Polymeropoulos, Vasilios M., et al.
Publicado: (2020) -
Tasimelteon safely and effectively improves sleep in Smith–Magenis syndrome: a double-blind randomized trial followed by an open-label extension
por: Polymeropoulos, Christos M., et al.
Publicado: (2021)